Article, 2024

Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study

Diabetes Technology and Therapeutics, ISSN 1520-9156, 10.1089/dia.2024.0022

Contributors

Laugesen C. 0000-0001-9253-9457 (Corresponding author) [1] [2] Ritschel T.K.S. 0000-0002-5843-240X [3] Ranjan A.G. 0000-0002-2253-6071 [1] Hsu L. [2] Jorgensen J.B. 0000-0001-9799-2808 [3] Svensson J. 0000-0002-9365-0728 [1] [4] Ekhlaspour L. 0000-0002-3263-1419 [5] Buckingham B. 0000-0003-4581-4887 [2] Norgaard K. 0000-0003-1620-8271 [1] [4]

Affiliations

  1. [1] Steno Diabetes Center
  2. [NORA names: Steno Diabetes Centers; Hospital; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Stanford University
  4. [NORA names: United States; America, North; OECD];
  5. [3] Technical University of Denmark
  6. [NORA names: DTU Technical University of Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  7. [4] University of Copenhagen
  8. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  9. [5] University of San Francisco
  10. [NORA names: United States; America, North; OECD]

Abstract

Objective: To evaluate the impact of missed or late meal boluses (MLBs) on glycemic outcomes in children and adolescents with type 1 diabetes using automated insulin delivery (AID) systems. Research Design and Methods: AID-treated (Tandem Control-IQ or Medtronic MiniMed 780G) children and adolescents (aged 6-21 years) from Stanford Medical Center and Steno Diabetes Center Copenhagen with ≥10 days of data were included in this two-center, binational, population-based, retrospective, 1-month cohort study. The primary outcome was the association between the number of algorithm-detected MLBs and time in target glucose range (TIR; 70-180 mg/dL). Results: The study included 189 children and adolescents (48% females with a mean ± standard deviation age of 13 ± 4 years). Overall, the mean number of MLBs per day in the cohort was 2.2 ± 0.9. For each additional MLB per day, TIR decreased by 9.7% points (95% confidence interval [CI] 11.3; 8.1), and compared with the quartile with fewest MLBs (Q), the quartile with most (Q) had 22.9% less TIR (95% CI: 27.2; 18.6). The age-, sex-, and treatment modality-adjusted probability of achieving a TIR of >70% in Q was 1.4% compared with 74.8% in Q (P < 0.001). Conclusions: MLBs significantly impacted glycemic outcomes in AID-treated children and adolescents. The results emphasize the importance of maintaining a focus on bolus behavior to achieve a higher TIR and support the need for further research in technological or behavioral support tools to handle MLBs.

Keywords

Medtronic MiniMed 780G, Tandem Control-IQ, automated insulin delivery, late meal bolus, missed meal bolus, type 1 diabetes

Funders

  • Medtronic
  • Zealand Pharma
  • Julie Von Müllen’s Foundation
  • Novo Nordisk
  • A.V. Lykfeldt and Wife
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • William-Demant Foundation
  • Danish Diabetes Association
  • Juvenile Diabetes Research Foundation International
  • JDFR

Data Provider: Elsevier